The toolkit has 11 elements, including good practice guidelines, disclosure checklists and template standard operating procedure. These documents are intended as an additional support to guide companies of all sizes through the different steps of the disclosure process.
"The ABPI is a strong advocate for transparency in clinical trial information,” said Stephen Whitehead, ABPI chief executive. “Earlier this year we committed to providing a clinical trial disclosure toolkit to companies and this is now available on our website for any company to use. The pharmaceutical industry has been, and continues to be, committed to addressing the issues relating to transparency in clinical research.
"Research is a truly global activity, with the U.K. supplying less than 2% of patients to global clinical trials. As part of a global industry, we are actively engaging with our European and international counterparts, as well as many other stakeholders, to input into ongoing discussions around clinical trial transparency."
